|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Prepaid expenses | |||||||||||||
| Accounts receivable, net | |||||||||||||
| Short-term investments | |||||||||||||
| Inventory | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Deferred cost of goods sold | |||||||||||||
| Restricted cash, current | |||||||||||||
| Total current assets | |||||||||||||
| Investments held in Trust Account | |||||||||||||
| Property, plant, and equipment, net | |||||||||||||
| Operating lease right-of-use assets | |||||||||||||
| Restricted cash, non-current | |||||||||||||
| Long-term inventory prepayment | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| Liabilities and Stockholders’ Equity: | |||||||||||||
| Accounts payable | |||||||||||||
| Accrued liabilities | |||||||||||||
| Accrued expenses - related party | |||||||||||||
| Deferred revenue, current | |||||||||||||
| Operating lease liabilities, current | |||||||||||||
| Debt, current | |||||||||||||
| Derivative liability | |||||||||||||
| Total current liabilities | |||||||||||||
| Deferred underwriting commissions | |||||||||||||
| Derivative warrant liability | |||||||||||||
| Debt, non-current | |||||||||||||
| Warrant liability | |||||||||||||
| Deferred revenue, non-current | |||||||||||||
| Operating lease liabilities, non-current | |||||||||||||
| Other long-term liabilities | |||||||||||||
| Total liabilities not subject to compromise | |||||||||||||
| Liabilities subject to compromise | |||||||||||||
| Total liabilities | |||||||||||||
| Class A ordinary shares; 13,658,271 and 21,359,616 shares subject to possible redemption at $10.00 per share at March 31, 2021 and December 31, 2020, respectively | |||||||||||||
| Stockholders’ equity: | |||||||||||||
| Common stock, $0.0001 par value; 1,000,000 shares authorized and 228,167 shares issued and outstanding as of September 30, 2023 (unaudited); 500,000 shares authorized and 226,265 shares issued and outstanding as of December 31, 2022 | |||||||||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,937,500 shares issued and outstanding at March 31, 2021 and December 31, 2020 | |||||||||||||
| Preferred stock, $0.0001 par value; 10,000 shares authorized and zero shares issued and outstanding as of September 30, 2023 (unaudited); 10,000 shares authorized, zero shares issued and outstanding as of December 31, 2022 | |||||||||||||
| Convertible preferred stock | |||||||||||||
| Convertible Preferred Stock | |||||||||||||
| Total preferred stock, $0.0001 par value; 10,000 shares authorized and zero shares issued and outstanding as of September 30, 2023 (unaudited); 10,000 shares authorized, zero shares issued and outstanding as of December 31, 2022 | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated deficit | |||||||||||||
| Accumulated other comprehensive loss | |||||||||||||
| Total stockholders’ equity | |||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||
Loading...
